Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about JNK3: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
JNK3 is a gene implicated in neurodegeneration research. Key relationships include: activates, therapeutic target, associated with. Associated with Neurodegeneration. Connected to 15 entities in the SciDEX knowledge graph.
| Gene Symbol | JNK3 |
| Aliases | MAPK10, c-Jun N-terminal Kinase 3 |
| Function | is a neuron-specific member of the MAPK family that plays critical roles in neuronal survival, stress responses, and synaptic plasticity. |
| Primary Expression | brain regions vulnerable to neurodegeneration: |
| Molecular Weight | 46 kDa |
| Amino Acids | 464 aa |
| Pathways | MAPK |
| Ensembl ID | ENSG00000109339 |
| GeneCards | JNK3 |
| Human Protein Atlas | JNK3 |
| Associated Diseases | neurodegeneration |
| Interactions | LRP2, PARP1, PI3K, MYELIN, JNK, MAPK10 |
| KG Connections | 58 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
JNK3["<b>JNK3</b>"]
AND["AND"]
JNK3 -->|"activates"| AND
Ferroptosis(["Ferroptosis"])
JNK3 -->|"activates"| Ferroptosis
Apoptosis(["Apoptosis"])
JNK3 -->|"activates"| Apoptosis
Mapk(["Mapk"])
JNK3 -->|"activates"| Mapk
neurodegeneration["neurodegeneration"]
JNK3 -->|"implicated in"| neurodegeneration
JNK["JNK"]
JNK -->|"activates"| JNK3
APOPTOSIS["APOPTOSIS"]
APOPTOSIS -->|"activates"| JNK3
MAPK10["MAPK10"]
MAPK10 -->|"activates"| JNK3
GENES["GENES"]
GENES -->|"activates"| JNK3
FERROPTOSIS["FERROPTOSIS"]
FERROPTOSIS -->|"activates"| JNK3
style JNK3 fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Neurodegeneration | therapeutic_target | disease | 0.65 |
| Stroke | activates | disease | 0.65 |
| Neuroinflammation | contributes_to | disease | 0.65 |
| Alzheimer | contributes_to | disease | 0.65 |
| Inflammation | contributes_to | disease | 0.65 |
| Parkinson | contributes_to | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Fibrosis | therapeutic_target | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| JNK | therapeutic_target | gene | 0.60 |
| JUN | associated_with | gene | 0.60 |
| LRP2 | activates | gene | 0.60 |
| JNK1 | expressed_in | gene | 0.60 |
| JUN | therapeutic_target | gene | 0.60 |
| UBIQUITIN | therapeutic_target | gene | 0.60 |
| JNK2 | expressed_in | gene | 0.60 |
| PARP1 | inhibits | gene | 0.60 |
| PI3K | inhibits | gene | 0.60 |
| Ferroptosis | activates | pathway | 0.60 |
| Apoptosis | activates | pathway | 0.60 |
| Mapk | activates | pathway | 0.60 |
| NEURODEGENERATIVE DISEASES | therapeutic_target | gene | 0.60 |
| MYELIN | activates | gene | 0.60 |
| ALZHEIMER | contributes_to | gene | 0.60 |
| AND | therapeutic_target | gene | 0.60 |
| APOPTOSIS | expressed_in | gene | 0.60 |
| NEURODEGENERATION | therapeutic_target | gene | 0.60 |
| C-JUN | therapeutic_target | gene | 0.60 |
| INFLAMMATION | contributes_to | gene | 0.60 |
| Proteasome | therapeutic_target | pathway | 0.60 |
| Mapk | therapeutic_target | pathway | 0.60 |
| Oxidative Stress | contributes_to | pathway | 0.60 |
| Apoptosis | expressed_in | pathway | 0.60 |
| Ubiquitin-Proteasome | therapeutic_target | pathway | 0.60 |
| MAPK signaling | participates_in | pathway | 0.60 |
| Alzheimer's disease | inhibits | disease | 0.60 |
| PI3K-AKT-mTOR signaling | participates_in | pathway | 0.60 |
| Wnt signaling | participates_in | pathway | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| JNK | activates | gene | 0.60 |
| MAPK10 | activates | gene | 0.60 |
| PERK | activates | gene | 0.60 |
| JNK | therapeutic_target | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| GENES | activates | gene | 0.60 |
| FERROPTOSIS | activates | gene | 0.60 |
| C-JUN | associated_with | gene | 0.60 |
| NEURODEGENERATION | therapeutic_target | gene | 0.60 |
| ASTROCYTES | activates | gene | 0.60 |
| ASTROCYTE | activates | gene | 0.60 |
| STROKE | activates | gene | 0.60 |
| AND | activates | gene | 0.60 |
| OLIGODENDROCYTE | activates | gene | 0.60 |
| NEURODEGENERATIVE DISORDERS | contributes_to | gene | 0.60 |
| ATP | therapeutic_target | gene | 0.60 |
| OXIDATIVE STRESS | contributes_to | gene | 0.60 |
| PARKINSON | contributes_to | gene | 0.60 |
| NEUROINFLAMMATION | contributes_to | gene | 0.60 |
| GSK3 | inhibits | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||